Publication of Biohit Oyj Annual Report 2016
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2016
Biohit Oyj’s CEO Semi Korpela will return to work on 20.2.2017
Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”.
Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare.